Newly diagnosed multiple myeloma patients with poor response to standard therapy
Ontology highlight
ABSTRACT: In this study, we analyzed transcriptome sequencing data to compare NDMM patients who were poor responders to the standard treatment approach (progression free survival < 24 months) to patients who were standard responders (progression free survival > 24 months).
ORGANISM(S): Homo sapiens
PROVIDER: GSE267013 | GEO | 2024/07/17
REPOSITORIES: GEO
ACCESS DATA